Financial Ratios EssilorLuxottica
Equities
EL
FR0000121667
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.25 EUR | +0.03% |
|
+1.08% | -35.81% |
| 15/05 | Less is more: Marc Jacobs sale shows LVMH cutting complexity as downturn drags on | RE |
| 14/05 | MPS-Mediobanca Takeover: Nattino's PC and Phone Seized | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.8 | 3.37 | 3.37 | 3.49 | 3.39 | |||||
Return on Total Capital | 3.34 | 4.07 | 4.04 | 4.15 | 4.02 | |||||
Return On Equity % | 4.69 | 6.16 | 6.3 | 6.24 | 6.07 | |||||
Return on Common Equity | 4.34 | 5.93 | 6.05 | 6 | 5.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.1 | 62.77 | 62.35 | 62.52 | 59.74 | |||||
SG&A Margin | 45.56 | 47.15 | 47.25 | 47.03 | 45.3 | |||||
EBITDA Margin % | 21.21 | 21.34 | 20.8 | 20.98 | 19.55 | |||||
EBITA Margin % | 18.12 | 18.5 | 17.98 | 18.04 | 16.61 | |||||
EBIT Margin % | 12.64 | 13.19 | 12.85 | 13.13 | 12.19 | |||||
Income From Continuing Operations Margin % | 8.14 | 9.31 | 9.55 | 9.4 | 8.57 | |||||
Net Income Margin % | 7.38 | 8.79 | 9.01 | 8.9 | 8.13 | |||||
Net Avail. For Common Margin % | 7.38 | 8.79 | 9.01 | 8.9 | 8.13 | |||||
Normalized Net Income Margin | 6.75 | 7.4 | 7.14 | 7.34 | 6.76 | |||||
Levered Free Cash Flow Margin | 20.06 | 10.58 | 12.73 | 12.21 | 11.51 | |||||
Unlevered Free Cash Flow Margin | 20.5 | 10.98 | 13.22 | 12.81 | 12.2 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.35 | 0.41 | 0.42 | 0.42 | 0.44 | |||||
Fixed Assets Turnover | 3.24 | 3.29 | 3.17 | 3.04 | 3.13 | |||||
Receivables Turnover (Average Receivables) | 8.86 | 9.57 | 8.91 | 8.47 | 8.19 | |||||
Inventory Turnover (Average Inventory) | 3.52 | 3.48 | 3.45 | 3.37 | 3.43 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.04 | 0.97 | 1 | 0.95 | 0.99 | |||||
Quick Ratio | 0.7 | 0.59 | 0.63 | 0.58 | 0.64 | |||||
Operating Cash Flow to Current Liabilities | 0.51 | 0.54 | 0.5 | 0.46 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 41.2 | 38.16 | 40.97 | 43.21 | 44.56 | |||||
Days Outstanding Inventory (Average Inventory) | 103.56 | 104.74 | 105.73 | 108.72 | 106.5 | |||||
Average Days Payable Outstanding | 90.57 | 87.07 | 89.66 | 89.2 | 85.24 | |||||
Cash Conversion Cycle (Average Days) | 54.18 | 55.83 | 57.04 | 62.73 | 65.81 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 36.16 | 31.99 | 29.97 | 32.23 | 36.46 | |||||
Total Debt / Total Capital | 26.56 | 24.24 | 23.06 | 24.38 | 26.72 | |||||
LT Debt/Equity | 30.95 | 26.72 | 23.03 | 23.91 | 23.97 | |||||
Long-Term Debt / Total Capital | 22.73 | 20.25 | 17.72 | 18.08 | 17.56 | |||||
Total Liabilities / Total Assets | 39.43 | 37.01 | 35.74 | 36.2 | 38.19 | |||||
EBIT / Interest Expense | 17.77 | 20.71 | 16.48 | 13.76 | 11.06 | |||||
EBITDA / Interest Expense | 34.93 | 39.43 | 31.36 | 25.81 | 20.9 | |||||
(EBITDA - Capex) / Interest Expense | 27.62 | 29.35 | 23.63 | 19.79 | 16.04 | |||||
Total Debt / EBITDA | 2.64 | 1.98 | 1.88 | 2.02 | 2.19 | |||||
Net Debt / EBITDA | 1.97 | 1.67 | 1.47 | 1.68 | 1.65 | |||||
Total Debt / (EBITDA - Capex) | 3.34 | 2.67 | 2.49 | 2.64 | 2.86 | |||||
Net Debt / (EBITDA - Capex) | 2.5 | 2.24 | 1.94 | 2.19 | 2.15 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 37.36 | 23.58 | 3.68 | 4.38 | 7.48 | |||||
Gross Profit, 1 Yr. Growth % | 50.38 | 27.51 | 3.01 | 4.89 | 2.82 | |||||
EBITDA, 1 Yr. Growth % | 107.66 | 33.1 | 3.31 | 7.48 | 1.66 | |||||
EBITA, 1 Yr. Growth % | 144.85 | 35.16 | 3.4 | 7.17 | 0.74 | |||||
EBIT, 1 Yr. Growth % | 464.41 | 43.75 | 4.75 | 10.26 | 2.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 982.55 | 42.68 | 6.4 | 2.68 | -1.93 | |||||
Net Income, 1 Yr. Growth % | 1.62T | 48.62 | 6.37 | 3.06 | -1.87 | |||||
Normalized Net Income, 1 Yr. Growth % | 956.27 | 54.16 | 4.26 | 11.34 | 1.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 1.63T | 48.62 | 5.18 | 0.98 | -2.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 14.58 | 14.36 | 8.67 | 10.81 | 11.43 | |||||
Inventory, 1 Yr. Growth % | 26.68 | 14.07 | -1.4 | 14.62 | 12.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 39.99 | 8.63 | 6.37 | 11.17 | -1.4 | |||||
Total Assets, 1 Yr. Growth % | 13.59 | 1.93 | -0.06 | 6.18 | -0.6 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.45T | -18.65 | -43.71 | -12.27 | -29.75 | |||||
Common Equity, 1 Yr. Growth % | 9.05 | 6.82 | 2.09 | 5.59 | -3.68 | |||||
Cash From Operations, 1 Yr. Growth % | 53.91 | 5.24 | 1.63 | 0.27 | 8.56 | |||||
Capital Expenditures, 1 Yr. Growth % | 58.46 | 52.62 | -2.61 | -0.59 | 0.2 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 44.37 | -31.65 | 28.35 | 2.21 | 2.46 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 43 | -30.69 | 28.3 | 3.18 | 3.48 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.56 | 28.69 | 22.29 | 0 | 1.27 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.76 | 30.29 | 13.19 | 4.03 | 5.92 | |||||
Gross Profit, 2 Yr. CAGR % | 6.6 | 38.17 | 14.6 | 3.84 | 3.78 | |||||
EBITDA, 2 Yr. CAGR % | 8.2 | 60.7 | 15.97 | 4.31 | 3.75 | |||||
EBITA, 2 Yr. CAGR % | 7.94 | 75.76 | 16.71 | 4.04 | 3 | |||||
EBIT, 2 Yr. CAGR % | 10.92 | 169.72 | 20.51 | 5.71 | 4.89 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 16.67 | 291.18 | 23.21 | 4.52 | 0.35 | |||||
Net Income, 2 Yr. CAGR % | 16.55 | 403.17 | 25.73 | 4.7 | 0.57 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.5 | 278.22 | 24.24 | 5.76 | 5.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.94 | 404.19 | 25.02 | 3.06 | -0.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.89 | 14.47 | 11.48 | 9.74 | 11.12 | |||||
Inventory, 2 Yr. CAGR % | 6.25 | 20.21 | 6.05 | 6.31 | 13.49 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.58 | 23.32 | 7.49 | 8.74 | 4.7 | |||||
Total Assets, 2 Yr. CAGR % | 6.31 | 7.59 | 0.93 | 3.01 | 2.75 | |||||
Tangible Book Value, 2 Yr. CAGR % | 235.71 | 258.18 | -32.33 | -29.73 | -21.42 | |||||
Common Equity, 2 Yr. CAGR % | 0.56 | 7.74 | 4.43 | 3.83 | 0.85 | |||||
Cash From Operations, 2 Yr. CAGR % | 17.38 | 27.27 | 3.42 | 0.95 | 4.33 | |||||
Capital Expenditures, 2 Yr. CAGR % | 6.8 | 55.51 | 21.92 | -1.6 | -0.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 83.06 | -2.99 | -7.65 | 13.36 | 1.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 77.26 | -2.72 | -6.97 | 13.91 | 2.75 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 20.35 | 25.45 | 10.59 | 0.63 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.31 | 12.1 | 20.74 | 10.18 | 5.17 | |||||
Gross Profit, 3 Yr. CAGR % | 21.56 | 12.99 | 25.28 | 11.19 | 3.45 | |||||
EBITDA, 3 Yr. CAGR % | 22.83 | 13.34 | 37.67 | 12.3 | 2.9 | |||||
EBITA, 3 Yr. CAGR % | 23.18 | 13.7 | 46.02 | 12.55 | 2.33 | |||||
EBIT, 3 Yr. CAGR % | 18.34 | 16.61 | 94.42 | 15.71 | 3.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.94 | 24.38 | 153.46 | 15.95 | 2.33 | |||||
Net Income, 3 Yr. CAGR % | 10.54 | 25.95 | 199.74 | 17.67 | 2.46 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.23 | 18.97 | 142.85 | 18.3 | 3.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -6.94 | 25.56 | 199.02 | 16.43 | 1.02 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.37 | 3.95 | 12.5 | 11.26 | 10.3 | |||||
Inventory, 3 Yr. CAGR % | 6.33 | 8.79 | 12.53 | 8.84 | 8.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.39 | 11.25 | 17.39 | 8.71 | 5.25 | |||||
Total Assets, 3 Yr. CAGR % | 7.08 | 4.82 | 4.98 | 2.65 | 1.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | 36.49 | 110.63 | 93.28 | -26.21 | -29.69 | |||||
Common Equity, 3 Yr. CAGR % | 2.27 | 2.48 | 5.82 | 4.81 | 1.26 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.43 | 13.18 | 18.07 | 2.36 | 3.42 | |||||
Capital Expenditures, 3 Yr. CAGR % | 13.2 | 20.3 | 33.05 | 13.9 | -1.01 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.78 | 29.75 | 5.51 | -5.13 | 9.17 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.37 | 27.64 | 5.72 | -4.34 | 9.91 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.16 | - | 20.99 | 16.32 | 7.39 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 22.74 | 21.68 | 18.58 | 8.8 | 14.58 | |||||
Gross Profit, 5 Yr. CAGR % | 23.7 | 21.29 | 18.62 | 9.23 | 16.14 | |||||
EBITDA, 5 Yr. CAGR % | 19.66 | 18.74 | 18.42 | 9.15 | 22.44 | |||||
EBITA, 5 Yr. CAGR % | 19.24 | 18.94 | 18.9 | 9.17 | 26.4 | |||||
EBIT, 5 Yr. CAGR % | 14.49 | 14.06 | 16.63 | 11.31 | 50.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.88 | 16.95 | 16.1 | 16.02 | 74.96 | |||||
Net Income, 5 Yr. CAGR % | 12.47 | 15.65 | 16.15 | 16.98 | 93.65 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.2 | 12.87 | 17.51 | 12.58 | 72.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.43 | 0.5 | 4.53 | 16.02 | 92.17 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.11 | 23.55 | 4.67 | 6.23 | 11.95 | |||||
Inventory, 5 Yr. CAGR % | 16.8 | 27.37 | 6.22 | 7.79 | 12.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 42.53 | 33.8 | 9.81 | 10.24 | 12.14 | |||||
Total Assets, 5 Yr. CAGR % | 35.18 | 43.18 | 4.57 | 4.09 | 4.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 37.45 | 41.44 | 3.48 | 35.77 | 34.85 | |||||
Common Equity, 5 Yr. CAGR % | 39.39 | 45.18 | 3.05 | 3.02 | 3.8 | |||||
Cash From Operations, 5 Yr. CAGR % | 30.65 | 24.44 | 15.56 | 8.12 | 12.37 | |||||
Capital Expenditures, 5 Yr. CAGR % | 28.5 | 18.81 | 16.61 | 11.01 | 18.6 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 30.07 | 15.81 | 7.46 | 22.24 | 3.55 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.58 | 15.61 | 7.58 | 21.3 | 4.11 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.85 | 16.12 | 14.13 | - | 12.4 |
- Stock Market
- Equities
- EL Stock
- Financials EssilorLuxottica
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















